KLF4 is a key determinant in the development and progression of cerebral cavernous malformations. - Wikidata - awgldk - TriplyDB

KLF4 is a key determinant in the development and progression of cerebral cavernous malformations.

KLF4 is a key determinant in the development and progression of cerebral cavernous malformations.

http://www.wikidata.org/entity/Q30278010

about

RHO binding to FAM65A regulates Golgi reorientation during cell migration Combined HMG-COA reductase and prenylation inhibition in treatment of CCM.The pathobiology of vascular malformations: insights from human and model organism genetics.Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation.Introduction to cerebral cavernous malformation: a brief review.Up-regulation of NADPH oxidase-mediated redox signaling contributes to the loss of barrier function in KRIT1 deficient endothelium.Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin.The molecular basis of endothelial cell plasticity.Krüppel-like factor 4 (KLF4): What we currently know.The Vascular Wall: a Plastic Hub of Activity in Cardiovascular Homeostasis and Disease.Vascular heterogeneity and specialization in development and disease.When endothelial cells go rogue.Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations.Endothelial TLR4 and the microbiome drive cerebral cavernous malformations.Organotypic vasculature: From descriptive heterogeneity to functional pathophysiology.Endothelial-to-mesenchymal transition in cardiovascular diseases: Developmental signaling pathways gone awry.Hypoxia-induced endothelial-mesenchymal transition is associated with RASAL1 promoter hypermethylation in human coronary endothelial cells.Endothelial Myocyte Enhancer Factor 2c Inhibits Migration of Smooth Muscle Cells Through Fenestrations in the Internal Elastic Lamina.Data in support of sustained upregulation of adaptive redox homeostasis mechanisms caused by KRIT1 loss-of-function.The Role of KLF in Alzheimer's Disease Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations

P2860

Q29147496-A71366A5-842F-4410-BDE6-51494C041E01 Q33737847-DD234BB1-8870-4B8F-BF47-FF4D399DEA08 Q34544980-F3FE531F-3F0B-4B2B-9AD6-9C95524CABE1 Q36892606-AB71F438-D6C3-43DD-8E3A-DCF0C5B43104 Q37239068-BC04B2BB-BD36-478F-B55B-1715F3606252 Q37351147-EFEB38D4-491E-4FC0-965B-733DD7C77D76 Q38622980-558A1C8D-4246-436B-9798-5C291569EA34 Q38957623-DD784F34-A50B-4115-B788-83F30F51548B Q39127982-6B0C6034-876D-478C-9C1B-C0313A440D1C Q39151066-70667FC7-3A13-4920-8674-1BDBDF8DAE3C Q39255920-733E7063-94BD-490E-9BBB-1A605AE8043E Q39326100-7AC5A559-EE35-4EEA-A78E-5654578CAFC5 Q41880390-AA66160F-2A5C-4BDF-BAA5-FEC8830E2568 Q46147842-9723CF11-05F8-427A-86B5-9ACDD67534AD Q46180887-E38206B6-13B4-4FCD-BB2B-F83D12C47BC0 Q47836465-CC17BE7F-3E42-4F9F-9464-28A5F9DFE51E Q48096975-2506B485-D01D-4189-BF14-524A4792D3B2 Q48746899-3FBFE789-BB1A-46DF-B4B6-9575FF9A4BF0 Q50672440-B06C5E69-6D81-4209-84B7-6BF72428D272 Q55042262-FCC6B394-6761-4CC7-9843-81E8CDE3B073 Q57299999-A7873DC3-9E35-4E4F-A3D0-9EDA834D62B9 Q58699724-851BA4EC-30BE-4BB0-975E-477CA99F651E Q58764066-398CBAE8-C2BF-4FE0-B86B-F6280A0C5429

P2860

KLF4 is a key determinant in the development and progression of cerebral cavernous malformations.

http://www.wikidata.org/entity/Q30278010

description

2015 nî lūn-bûn

@nan

2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

KLF4 is a key determinant in t ...... ebral cavernous malformations.

@ast

KLF4 is a key determinant in t ...... ebral cavernous malformations.

@en

type

label

KLF4 is a key determinant in t ...... ebral cavernous malformations.

@ast

KLF4 is a key determinant in t ...... ebral cavernous malformations.

@en

prefLabel

KLF4 is a key determinant in t ...... ebral cavernous malformations.

@ast

KLF4 is a key determinant in t ...... ebral cavernous malformations.

@en

P1433

Q30278010-1CE8B87E-9E72-4A40-A8D5-24482B224FA5

P1476

Q30278010-66D709EA-A08A-4E35-9654-23A5ADCBF4FA

P2093

Q30278010-05ABEF76-29BA-4D2B-A65A-65F1550BCFD8

Q30278010-15D0CCC0-341D-4D20-A478-CD821110E9A8

Q30278010-2F3DE1FF-AE52-4753-BABE-3B1AEE38B1C7

Q30278010-6417ECEA-F496-4240-B32E-95FA50E5094B

Q30278010-6EB7BB5A-3364-426C-9B7A-22D9CCCBD433

Q30278010-A2F75350-654D-42D0-8852-19957B7CB4EA

Q30278010-AA87F52B-2C0E-4052-AEC9-0A929CBC8EFB

Q30278010-D100F958-4416-4087-882A-11B13FC5B704

Q30278010-D9A880C7-4B19-49AB-B002-DA0EAF89502D

Q30278010-E7C68537-F03F-41FD-81AA-E969716DA02B

P2860

Q30278010-032B9E50-95F4-4645-84E1-733F6A9B1002

Q30278010-0616ECE7-0BDC-4C2B-AE4D-31760E1B5AB0

Q30278010-0E4A9546-1AEB-4C66-82E4-D1BC269CF336

Q30278010-12292B7A-BEC8-43B9-A0B1-4B71F6962B9E

Q30278010-160ECA97-37D6-4859-8EF1-D67C46F2E48E

Q30278010-16B562EC-EA7E-4F4D-9899-437A7558F163

Q30278010-18FFF642-1EC7-4334-808E-BB8BFAD7A5F1

Q30278010-1B83D85A-2203-48AA-B5D4-C7A2E34A9507

Q30278010-1F88CF54-16B2-4D06-9BDB-EBB92A151D44

Q30278010-25082275-ABCC-41EC-9283-91FF2A5F6551

P304

Q30278010-B74C32D7-99D8-4D16-A07E-1174514F7E01

P31

Q30278010-0EE22BC4-A89A-474F-87A6-26F2E97873CC

P356

Q30278010-5F925765-03AD-4E3A-8B85-A2126D7F4CCB

P433

Q30278010-5A1985D3-E527-4D68-9504-494032208382

P478

Q30278010-BA751849-C2E9-4FC9-906D-5BD86BA141C8

P50

Q30278010-1A95625B-9280-47A3-AF1E-35E7D2BF6B32

Q30278010-612B0380-1DD0-43BF-A206-5DBE4EC864E3

Q30278010-68847F30-62C0-4140-AD1E-1B5092BD2A59

Q30278010-D69486F4-540D-47A8-B276-087390682068

Q30278010-E1B04026-EC9E-4D62-B438-13C2BF896F79

P577

Q30278010-E7E3B414-25D7-476A-9791-8ADD6FB3E438

P698

Q30278010-CA5A70D7-BD34-4DC7-B293-E5E6AA6F1536

P932

Q30278010-A9699B0C-1D06-47BB-A5C0-ECAE2ADC1237

P356

P1433

EMBO Molecular Medicine

P1476

KLF4 is a key determinant in t ...... ebral cavernous malformations.

@en

P2093

Costanza Giampietro

http://www.w3.org/2001/XMLSchema#string

Eleanna Papa

http://www.w3.org/2001/XMLSchema#string

Gary K Owens

http://www.w3.org/2001/XMLSchema#string

Luca Bravi

http://www.w3.org/2001/XMLSchema#string

Luigi Maddaluno

http://www.w3.org/2001/XMLSchema#string

Marco Francesco Morini

http://www.w3.org/2001/XMLSchema#string

Martin Schwartz

http://www.w3.org/2001/XMLSchema#string

Monica Corada

http://www.w3.org/2001/XMLSchema#string

Mukesh K Jain

http://www.w3.org/2001/XMLSchema#string

Noemi Rudini

http://www.w3.org/2001/XMLSchema#string

P2860

KRIT1 regulates the homeostasis of intracellular reactive oxygen species

Krit 1 interactions with microtubules and membranes are regulated by Rap1 and integrin cytoplasmic domain associated protein-1

Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein

CCM1 regulates vascular-lumen organization by inducing endothelial polarity

Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest

Erk5 activation elicits a vasoprotective endothelial phenotype via induction of Kruppel-like factor 4 (KLF4)

A gene for a novel zinc-finger protein expressed in differentiated epithelial cells and transiently in certain mesenchymal cells

Gas1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosis

Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling.

Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations

P304

6-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15252/EMMM.201505433

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Maria Grazia Lampugnani

Elisabetta Dejana

Roberto Cuttano

Nicolas Baeyens

P577

2015-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26612856

http://www.w3.org/2001/XMLSchema#string

P932

4718159

http://www.w3.org/2001/XMLSchema#string